ArticleBMC infectious diseases2025
Pandemic shadows in the operating room how COVID-19 altered the risk and timing of surgical site infections: a multivariable risk assessment and time-to-event analysis in a cohort of abdominal surgery patients.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interpreting Abdominal Surgical-Site Infection Trends Across the COVID-19 Shock: A Critical Narrative Review and the SSI Signal-Validity Framework.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurgical site infections (SSIs) are among the most frequent and preventable complications following abdominal surgery, influenced by patient, procedural, and systemic factors. The coronavirus disease 2019 (COVID-19) pandemic introduced new perioperative protocols-including universal masking, visitor restrictions, enhanced personal protective equipment (PPE) use, and modified operating-room workflows-that may have altered infection dynamics. This retrospective cohort study, conducted in a large tertiary center in Saudi Arabia, examined whether these changes affected SSI risk and timing using survival analysis.
objectivesTo determine SSI incidence, identify independent risk factors, and assess how the COVID-19 pandemic influenced infection onset and outcomes among patients undergoing abdominal surgery.
methodsWe reviewed 809 adult abdominal-surgery cases between January 2019 and December 2022. Data were extracted from the hospital's electronic health-record system by two independent reviewers using a standardized form under institutional approval (IRB No. E-22-6926). Data confidentiality was strictly maintained. SSIs were defined according to the U.S. Centers for Disease Control and Prevention (CDC) criteria. Multivariable logistic regression identified independent predictors, while Kaplan-Meier and Cox regression analyses evaluated infection-free survival and time-to-event outcomes.
resultsOf 809 patients, 47 (5.8%) developed SSIs, a rate consistent with international benchmarks. Independent predictors included diabetes mellitus (adjusted odds ratio [OR] 2.14; 95% CI 1.05-4.34), contaminated wounds (OR 3.67; 95% CI 1.58-8.54), and postoperative hyperglycemia ≥ 7 mmol/L (OR 2.95; 95% CI 1.32-6.57). During the pandemic, infections occurred later in the postoperative course, suggesting a delayed onset despite similar median times to infection. No multicollinearity was observed, and model diagnostics confirmed stability.
conclusionSSIs remain a significant postoperative concern. Diabetes, wound contamination, and hyperglycemia were consistent predictors. Pandemic-related procedural adaptations may have delayed infection onset, underscoring the need for extended postoperative surveillance and context-specific infection-control strategies during public-health emergencies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.